EDGAR Filing Documents for 0001144204-17-057839

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001144204-17-057839

Filing Date

2017-11-09

Accepted

2017-11-09 17:21:12

Documents

Effectiveness Date

2017-11-09

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-8	tv479043_s8.htm	S-8	58660
2	EXHIBIT 5.1	tv479043_ex5-1.htm	EX-5.1	13691
3	EXHIBIT 23.1	tv479043_ex23-1.htm	EX-23.1	2452
4	EXHIBIT 23.2	tv479043_ex23-2.htm	EX-23.2	3684
5	GRAPHIC	image_001.jpg	GRAPHIC	3142
	Complete submission text file	0001144204-17-057839.txt		83970

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014

Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366

Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)